Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.

PatientApr 16, 2026 (epub)
Clinical ResearchNeurologyOpen access

Carla Dias-Barbosa, Hisaka Igarashi, Ashley Duenas et al.

✦ AI-curated · Sources linked

In 30 seconds

This qualitative study explored the experiences of 41 adults with migraine in Japan who participated in a phase III randomized controlled trial of erenumab. Participants reported significant improvements in migraine frequency, severity, and duration after 24 weeks of treatment, leading to enhanced daily functioning and quality of life. Satisfaction with erenumab averaged 6.8 on a 0-10 scale.

Key findings

  • Participants reported significant reductions in migraine frequency, severity, and duration after treatment.
  • Satisfaction with erenumab was high, with a mean score of 6.8 on a 0-10 scale.
  • Migraine symptoms such as pain, nausea, and fatigue were identified as the most bothersome prior to treatment.
  • Patients experienced improved daily functioning and quality of life due to treatment.

Why it matters

Understanding the lived experiences of migraine patients and their responses to new treatments like erenumab can inform clinical practice and enhance patient care strategies, ultimately improving quality of life for those affected by migraine.

Source

Published in Patient. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.